Below are links to external websites of associations and professional organizations of interest to pharmacoepidemiologists
MedWatch, the FDA Medical Products Reporting Program, is an initiative designed both to educate all health professionals about the critical importance of being aware of, monitoring for, and reporting adverse events and problems to FDA and/or the manufacturer and; to ensure that new safety information is rapidly communicated to the medical community thereby improving patient care.
The purpose of the MedWatch program is to enhance the effectiveness of postmarketing surveillance of medical products as they are used in clinical practice and to rapidly identify significant health hazards associated with these products.
MedWatch has four goals:
ISPE is a MedWatch Partner. ISPE works with the FDA to help keep its members informed about the FDA Medical Products Reporting and Safety Information Program and encourage them to play an active role in postmarketing surveillance.
FDA Guidance, Regulatory and Compliance Information
Information from the Center for Drug Evaluation and Research branch of the FDA